Trial Profile
A Randomized, Double-blind, Placebo-controlled Study of Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Dexlansoprazole (Primary)
- Indications Laryngopharyngeal reflux
- Focus Therapeutic Use
- 08 Apr 2011 New trial record